FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

16530211000001104: Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58005101000001111 Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58005201000001116 Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has VMP Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has specific active ingredient Insulin lispro true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has specific active ingredient Insulin lispro protamine true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has dispensed dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Insulin lispro true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has basis of strength substance Insulin lispro true Inferred relationship Existential restriction modifier
Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Has unit of administration Unit false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Humalog Mix25 100units/ml suspension for injection 10ml vials (Eli Lilly and Company Ltd) 1 vial Is a True Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start